NCT05951777 - Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Traumatic Brain Injury

Interventions

BIOLOGICAL

Autologous HB-adMSCs

Hope Biosciences autologous adipose-derived mesenchymal stem cells

DRUG

Normal Saline

Sterile Saline Solution 0.9%

Trial Locations (2)

RECRUITING

Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston

RECRUITING

The University of Texas Health Science at San Antonio, San Antonio